Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy

INTRODUCTION: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers. CASE PRESENTATION: We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Homaei Shandiz, Fatemeh, Kadkhodayan, Sima, Hsanzade Mofrad, Malihe, Yousefi Roodsari, Zohre, Sharifi Sistani, Noorieh, Nabizadeh Marvast, Majid, Sadeghei, Mahbobe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270657/
https://www.ncbi.nlm.nih.gov/pubmed/25593719
http://dx.doi.org/10.5812/ircmj.14919
Descripción
Sumario:INTRODUCTION: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers. CASE PRESENTATION: We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy. CONCLUSIONS: Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.

Ejemplares similares